X hits on this document

44 views

0 shares

0 downloads

0 comments

6 / 19

Mark S. Luer, Pharm.D. page 6

IX. SPEAKING ENGAGEMENTS:

NATIONAL “How to Train Future Pharmacy Faculty.” American College of Clinical Pharmacy. San Francisco, CA. October 2005. (Invited Discussion Leader)

“Utilization and Limitations of Microdialysis.” Society of Critical Care Medicine. Orlando, FL. February 2004. (Invited Lecture)

“Intracerebral Microdialysis: Experimental and Clinical Applications.” American Epilepsy Society, Annual Meeting. Seattle, WA. December 2002. (Invited Lecture)

“CNS Minisabbatical Experience.” American College of Clinical Pharmacy, Annual Meeting. Albuquerque, NM. October 2002. (Invited Lecture)

“Microdialysis: Experimental and Clinical Applications in Neuroscience.” American College of Clinical Pharmacy, Annual Meeting. Savannah, GA. April 2002. (Invited Lecture)

“Designing a Microdialysis Experiment.” American College of Clinical Pharmacy, Annual Meeting. Savannah, GA. April 2002. (Invited Lecture)

“Blood-Brain Barrier P-glycoprotein Function is Reduced in Aged Rats.” Experimental Biology Annual Meeting (American Society for Pharmacology and Experimental Therapeutics). New Orleans, LA. April 2002 (Poster).

“Navigating Your Academic Career. Preparing from the First Day of Your Appointment.” American College of Clinical Pharmacy, Annual Meeting. Tampa, FL. October 2001. (Invited Lecture)

“Antiepileptic Drugs in Development.” Annual ASHP Midyear Clinical Meeting and Exhibits. Las Vegas. December 2000. (Invited Lecture)

“Drug-Cytokine Interactions: IL-6 Impact on Blood-Brain Barrier Transport.” American College of Clinical Pharmacy, Annual Meeting. Los Angeles, CA. November 2000. (Poster)

“Oxidative Stress and Neurologic Disorders: Putative Role of Antioxidant Therapy.” Annual ASHP Midyear Clinical Meeting and Exhibits. Orlando, Florida. December 1999. (Invited Lecture)

“Interventions to Achieve Tonic Exposure to Levodopa: Delaying or Preventing the Onset of Motor Complications.” Annual ASHP Midyear Clinical Meeting and Exhibits. Las Vegas, Nevada. December 1998. (Invited Lecture)

“Anticonvulsant Activity of System-L Inhibition.” American Epilepsy Society. San Francisco, California. December 1998. (Poster)

“Competitive Inhibition of Gabapentin Brain Uptake in the Rat.” American College of Clinical Pharmacy, Annual Meeting. Cincinnati, Ohio. November 1998. (Poster)

“Growth Factors as Neurotrophins in Neurological Diseases.” American College of Clinical Pharmacy, Annual Meeting. Phoenix, Arizona. November 1997. (Invited Lecture)

“Dose-Dependent Transport of Gabapentin at the Blood-Brain Barrier.” American College of Clinical Pharmacy. Annual Meeting. Ft. Lauderdale, Florida; 1997. (Poster).

"Epidemiology and Pathophysiology of CNS Injury." Annual ASHP Midyear Clinical Meeting and Exhibits. New Orleans, Louisiana. December 1996. (Invited Lecture)

Document info
Document views44
Page views44
Page last viewedMon Dec 05 10:40:54 UTC 2016
Pages19
Paragraphs522
Words6688

Comments